C.R. Bard to acquire Liberator Medical for roughly $181M C.R. Bard (BCR) announced that it has entered into a definitive agreement to acquire Liberator Medical Holdings (LBMH) for $3.35 per share, or approximately $181M. This transaction is structured as a merger, has been approved by each company's board of directors, and is subject to customary closing conditions, including approval of the shareholders of Liberator and regulatory approvals. The company expects the transaction to close in the first quarter of 2016 and add approximately $70M to 2016 net sales and to be slightly accretive to adjusted cash earnings per share in 2016. The company estimates that in 2017 this acquisition will increase the organic revenue growth rate of the company and contribute between 5c-10c of adjusted cash earnings per share.